Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Nanobiotix's first immuno-oncology trial approved by U.S. FDA
Tuesday, December 26, 2017Nanobiotix SA Announces that the US Food and Drug Administration FDA has approved its Investigational New Drug IND Application for NBTXR a firstinclass nanoparticle designed for direct injection into cancerous tumors activated by stereotactic ablativ...
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
Tuesday, December 26, 2017HyLeukin is an immunooncology agent comprised of an optimally engineered Interleukin IL molecule based on Genexines proprietary longacting platform technology Genexine will establish a joint development committee with IMab to pursue global commercial...
MRA Applauds FDA Approval of Nivolumab to Reduce the Risk of Melanoma Returning After Surgery
Friday, December 22, 2017The Melanoma Research Alliance MRA applauds the US Food Drug Administration FDA approval of BristolMyers Squibbs BMS nivolumab Opdivo for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have...
Roche and Ignyta Reach Definitive Merger Agreement
Friday, December 22, 2017Roche and Ignyta Inc today announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US per share in an allcash transaction This corresponds to a total transaction value of US billion on a fully...
Confo Therapeutics Enters Into Drug Discovery Collaboration with Roche
Thursday, December 21, 2017Confo Therapeutics an emerging drug discovery company announced today that it has entered into a research collaboration and license agreement with Roche for the discovery development and commercialisation of novel small molecule agonists of an undisc...
Millendo Therapeutics Announces Acquisition of Alize Pharma SAS
Thursday, December 21, 2017Millendo Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing novel treatments for endocrine diseases today announced that it has acquired Aliz Pharma SAS in a stockbased transaction The acquisition of Aliz Pharma SAS t...
Precision Medicine Group Lands Major New Investment
Wednesday, December 20, 2017Precision Medicine Group PMG announced that it has reached an agreement for a million investment that positions the company for the next phase of growth The transaction is being led by Berkshire Partners and TPG Growth and also includes significant...
Otsuka Pharmaceutical and X-Chem Enter into a Drug Discovery Research and License Collaboration
Wednesday, December 20, 2017Otsuka Pharmaceutical Co Ltd Otsuka and XChem Inc XChem announce that they have signed a collaborative research agreement to advance the discovery process for new Otsuka drug compounds Under the terms of the agreement XChem will utilize its DNAenc...
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Tuesday, December 19, 2017Novartis announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents years of age or older with relapsing multiple sclerosis MS Fingolimod also know...
Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration
Tuesday, December 19, 2017Regeneron Pharmaceuticals Inc and ISA Pharmaceuticals BV a clinicalstage immunotherapy company today announced a clinical collaboration to advance ISA an immunotherapy targeting human papillomavirus type HPVinduced cancer in combination with cemipli...
